ChitogenX Inc.
CHGX
Rangering i aksjer
#39855
ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and... ChitogenX Inc. is a Canadian biologics firm specializing in orthopaedic and sports medicine. The company is dedicated to the research and development of innovative therapeutic technologies designed to improve the success rates of soft tissue repair in sports medicine surgeries. Its product pipeline features several biomaterial-based treatments, including Ortho-R for rotator cuff repair, Ortho-M for meniscus repair, and Ortho-C for articular cartilage repair. Additionally, they are developing Ortho-V to address osteoarthritis healing and ORTHO-T for tendon regeneration. Established in 2015, the company underwent a name change from Ortho Regenerative Technologies Inc. to ChitogenX Inc. in September 2022. It maintains its headquarters in Kirkland, Canada.
Aksjekurs
$0.00365786
Sist synkronisert: 2025-07-07
Markedsverdi
$293.82K
Endring (1 dag)
-0.43%
Endring (1 år)
-28.28%
Land
CA
Handel ChitogenX Inc. (CHGX)
Kategori
Healthcare
Markedsverdi av ChitogenX Inc.(CHGX)
Markedsverdi: $293.82K
Per October 2026 har ChitogenX Inc. en markedsverdi på $293.82K. Dette gjør ChitogenX Inc. til det 39855th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for ChitogenX Inc. fra 2020 til 2026
CHGX sammenlignet med topp 5 mest populære stocks
| Pris på CHGX | Eiendel B | Markedsverdi for B | Resultater | |
|---|---|---|---|---|
$62,156.49
$627.63K
|
$5.167T | +823,264,640.63% | ||
|
$60,324.88
$627.63K
|
$5.015T | +799,004,913.52% | ||
|
$49,421.69
$627.63K
|
$4.108T | +654,591,831.54% | ||
|
$46,937.63
$627.63K
|
$3.902T | +621,690,420.24% | ||
|
$32,352.59
$627.63K
|
$2.689T | +428,511,065.17% |
